QIAGEN N.V.'s Q4 Earnings Meet Estimates, Revenues Up Y/Y, Stock Down 0.9%

QIAGEN N.V. reported Q4 2025 adjusted EPS of 62 cents, meeting estimates and up 1.6% YoY. Net sales were $540.4 million, up 3.7% YoY, and total revenues for 2025 were $2.09 billion, up 5.7% YoY. The stock price dipped 0.9% after the announcement. QIAGEN's Q4 revenue breakdown shows Sample technologies revenues up 8% and Diagnostic solutions revenues up 3% on a reported basis.